Product Pipeline

Our extended delivery platform has been designed for continuous, extended release of a variety drugs without the need for either intravenous (IV) access or multiple dosing events.  PRF is an an oil-based, viscous, water-free formulation, giving it a physical – chemical characteristic that is adaptable for the delivery of different classes and types of currently injectable drugs, improving accessibility  in difficult to reach tissues, such as bone or poorly vascularized limbs.  In addition we are working to develop the sustained delivery of cancer chemotherapeutics that currently require repeated administration.

  • Pre-clinical
  • Phase I
  • Phase II
  • Phase III
  • NDA
  • Approval

PRF-110

Indication: Post-surgical pain

PRF-120

Indication: Nerve block to treat neuropathic pain and the delivery of local anesthesia. The product has a reduced viscosity.

PRF-130

Indication: Osteomyelitis

PRF-140

Indication: sustained release cancer chemotherapeutics